Provided by Tiger Trade Technology Pte. Ltd.

AstraZeneca PLC

160.17
+0.53000.33%
Post-market: 156.10-4.0700-2.54%19:59 EDT
Volume:2.23M
Turnover:356.02M
Market Cap:248.42B
PE:23.98
High:161.51
Open:161.43
Low:158.13
Close:159.64
52wk High:212.71
52wk Low:145.79
Shares:1.55B
Float Shares:1.50B
Volume Ratio:0.64
T/O Rate:0.15%
Dividend:3.16
Dividend Rate:1.97%
EPS(TTM):6.68
EPS(LYR):6.54
ROE:21.96%
ROA:8.02%
PB:4.94
PE(LYR):24.49

Loading ...

AstraZeneca Advances Off‑the‑Shelf CAR‑T Program in Tough‑to‑Treat Multiple Myeloma

TIPRANKS
·
Aug 28

Amgen, AstraZeneca announce Crossing trial showed ‘meaningful’ improvements

TIPRANKS
·
Aug 27

Amgen, AstraZeneca report CROSSING trial met co-primary and secondary endpoints

TIPRANKS
·
Aug 27

AstraZeneca, Amgen Phase 3 Trial Shows Tezspire Eases Swallowing Difficulties for EoE Patients

MT Newswires Live
·
Aug 27

AstraZeneca's Tezspire Meets Esophagitis Late-Stage Trial Goals

Dow Jones
·
Aug 27

AstraZeneca Slides Wednesday, Underperforms Market

Dow Jones
·
Aug 27

AstraZeneca Deepens Its Type 2 Diabetes Pipeline With New Global Patient Mapping Study

TIPRANKS
·
Aug 26

AstraZeneca Climbs Tuesday, Outperforms Market

Dow Jones
·
Aug 26

AstraZeneca (AZN) Receives a Sell from Deutsche Bank

TIPRANKS
·
Aug 25

Astrazeneca Prices $2.97 Billion Eurobond Offering

MT Newswires Live
·
Aug 25

AstraZeneca’s AZD4144 Interaction Study Adds Quiet Support to AZN’s Pipeline Story

TIPRANKS
·
Aug 25

AstraZeneca PLC Stock Falls Monday, Underperforms Market

Dow Jones
·
Aug 25

AstraZeneca Rallies Friday, Outperforms Market

Dow Jones
·
Aug 22

AstraZeneca’s SELENE 3 Trial Targets Extra Weight-Loss Upside for AZN Investors

TIPRANKS
·
Aug 21

AstraZeneca PLC Stock Rises Thursday, Outperforms Market

Dow Jones
·
Aug 21

Dizhe Pharma Surpasses 500 Million Yuan in First-Half Revenue, Seals Global Exclusive Licensing Pact with AstraZeneca for Sunvozertinib

Deep News
·
Aug 20

Third Indication Approved in China for AstraZeneca's Ultomiris

Stock News
·
Aug 20

Goldman Sachs Sticks to Their Buy Rating for AstraZeneca (AZN)

TIPRANKS
·
Aug 20

AstraZeneca PLC Stock (AZN) Moved Up by 3.40% on Aug 19: What Signal Does It Send?

TradingKey
·
Aug 20

Movement Alert|AstraZeneca PLC Rises 3.1% in Regular Trading, Multiple Positive Phase III Lung Cancer Results Coupled with Pharma Sector Strength

Market Focus
·
Aug 19